ペプチドリームの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/11/21 | 2,539.5 | 2,587 | 2,503 | 2,563.5 | +7.5 | +0.3% | 764,000 |
2024/11/20 | 2,520 | 2,597 | 2,452.5 | 2,556 | +6 | +0.2% | 1,099,900 |
2024/11/19 | 2,574 | 2,603.5 | 2,530 | 2,550 | -24.5 | -1% | 908,700 |
2024/11/18 | 2,740 | 2,751.5 | 2,558 | 2,574.5 | -310 | -10.7% | 2,147,200 |
2024/11/15 | 2,830 | 2,944 | 2,713 | 2,884.5 | -21.5 | -0.7% | 1,535,300 |
2024/11/14 | 2,600 | 2,960 | 2,562 | 2,906 | +157.5 | +5.7% | 2,822,200 |
2024/11/13 | 2,827 | 2,827 | 2,704 | 2,748.5 | -79 | -2.8% | 959,800 |
2024/11/12 | 2,796.5 | 2,859.5 | 2,791.5 | 2,827.5 | +17.5 | +0.6% | 548,400 |
2024/11/11 | 2,840 | 2,845 | 2,766 | 2,810 | +11.5 | +0.4% | 435,300 |
2024/11/08 | 2,785 | 2,829.5 | 2,773 | 2,798.5 | +53 | +1.9% | 547,500 |
2024/11/07 | 2,884 | 2,907 | 2,743 | 2,745.5 | -108 | -3.8% | 759,600 |
2024/11/06 | 2,802 | 2,879.5 | 2,801 | 2,853.5 | +52 | +1.9% | 626,100 |
2024/11/05 | 2,732 | 2,822.5 | 2,731 | 2,801.5 | +101.5 | +3.8% | 584,600 |
2024/11/01 | 2,732 | 2,777 | 2,693 | 2,700 | -138 | -4.9% | 757,000 |
2024/10/31 | 2,808 | 2,855.5 | 2,775.5 | 2,838 | +3 | +0.1% | 471,800 |
2024/10/30 | 2,853 | 2,866 | 2,798.5 | 2,835 | -2 | -0.1% | 787,000 |
2024/10/29 | 2,780 | 2,844 | 2,751 | 2,837 | +56 | +2% | 622,500 |
2024/10/28 | 2,700 | 2,803 | 2,698.5 | 2,781 | +95.5 | +3.6% | 567,800 |
2024/10/25 | 2,739.5 | 2,755.5 | 2,672.5 | 2,685.5 | -68.5 | -2.5% | 582,100 |
2024/10/24 | 2,780 | 2,789.5 | 2,740.5 | 2,754 | -64.5 | -2.3% | 696,000 |
2024/10/23 | 2,854 | 2,865 | 2,808 | 2,818.5 | -24 | -0.8% | 456,300 |
2024/10/22 | 2,930 | 2,930 | 2,807 | 2,842.5 | -125.5 | -4.2% | 1,001,700 |
2024/10/21 | 2,950 | 3,060 | 2,943.5 | 2,968 | +18 | +0.6% | 1,083,300 |
2024/10/18 | 2,940 | 2,958.5 | 2,908 | 2,950 | +8 | +0.3% | 966,300 |
2024/10/17 | 2,888.5 | 2,959 | 2,868 | 2,942 | +85 | +3% | 940,300 |
2024/10/16 | 2,844 | 2,904 | 2,826.5 | 2,857 | -56 | -1.9% | 720,400 |
2024/10/15 | 2,740 | 2,930 | 2,711 | 2,913 | +173 | +6.3% | 1,128,800 |
2024/10/11 | 2,705 | 2,763 | 2,696 | 2,740 | +19.5 | +0.7% | 449,500 |
2024/10/10 | 2,702 | 2,763.5 | 2,675.5 | 2,720.5 | -19 | -0.7% | 495,200 |
2024/10/09 | 2,760 | 2,771 | 2,697 | 2,739.5 | -2.5 | -0.1% | 560,400 |
2024/10/08 | 2,787.5 | 2,801 | 2,701.5 | 2,742 | -116.5 | -4.1% | 1,176,600 |
2024/10/07 | 2,900 | 2,949 | 2,847.5 | 2,858.5 | +22.5 | +0.8% | 1,160,200 |
2024/10/04 | 2,735.5 | 2,850 | 2,725.5 | 2,836 | +72 | +2.6% | 916,900 |
2024/10/03 | 2,721.5 | 2,813 | 2,696.5 | 2,764 | +110 | +4.1% | 1,066,400 |
2024/10/02 | 2,680 | 2,734.5 | 2,603.5 | 2,654 | -75 | -2.7% | 912,800 |
2024/10/01 | 2,655 | 2,766 | 2,589.5 | 2,729 | +68 | +2.6% | 760,000 |
2024/09/30 | 2,619.5 | 2,722.5 | 2,601 | 2,661 | -58.5 | -2.2% | 890,600 |
2024/09/27 | 2,748 | 2,789 | 2,651 | 2,719.5 | +5 | +0.2% | 1,119,100 |
2024/09/26 | 2,692.5 | 2,714.5 | 2,643 | 2,714.5 | +44 | +1.6% | 984,300 |
2024/09/25 | 2,600 | 2,677 | 2,586 | 2,670.5 | +109.5 | +4.3% | 939,300 |
2024/09/24 | 2,574.5 | 2,610 | 2,537.5 | 2,561 | +25 | +1% | 777,700 |
2024/09/20 | 2,557.5 | 2,631.5 | 2,516.5 | 2,536 | +113 | +4.7% | 1,576,400 |
2024/09/19 | 2,450.5 | 2,496 | 2,423 | 2,423 | +5 | +0.2% | 489,600 |
2024/09/18 | 2,407 | 2,455 | 2,378 | 2,418 | +18 | +0.8% | 424,500 |
2024/09/17 | 2,452.5 | 2,462.5 | 2,350 | 2,400 | -67.5 | -2.7% | 644,000 |
2024/09/13 | 2,491 | 2,510 | 2,433 | 2,467.5 | -50 | -2% | 530,900 |
2024/09/12 | 2,525 | 2,558 | 2,492 | 2,517.5 | +35.5 | +1.4% | 438,500 |
2024/09/11 | 2,537.5 | 2,606 | 2,451 | 2,482 | -68 | -2.7% | 667,300 |
2024/09/10 | 2,510 | 2,579.5 | 2,477.5 | 2,550 | +40.5 | +1.6% | 457,000 |
2024/09/09 | 2,421 | 2,515.5 | 2,410.5 | 2,509.5 | -14.5 | -0.6% | 716,700 |
151~
200
件表示中 / 2950件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ペプチド | 153,400円 | +5.0% | +1.5% | 0.00% | 13.12倍 | 3.49倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 309,900円 | +8.0% | -15.3% | 4.00% | 8.70倍 | 0.84倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
サワイGHD | 180,400円 | +5.9% | +684.6% | 3.05% | 11.97倍 | 1.19倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
キッセイ薬 | 400,000円 | +3.6% | +6.1% | 3.00% | 13.47倍 | 0.79倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.43倍 | 1.46倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
市場注目の銘柄
チャート関連のコラム